Agilent Technologies, Inc. (A)

118.65 +0.96 (+0.82%) USD  |  NYSE  |  May 07, 16:00
118.66 +0.01 (+0.01%) Pre-Market: 08:43
More

Agilent Technologies Research and Development Expense (Annual) : 450.00M for Oct. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for A.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Bio-Rad Laboratories, Inc. 257.60M
Revvity, Inc. 215.84M
Bruker Corp. 395.20M
Azenta, Inc. 30.39M
Harvard Bioscience, Inc. 8.825M